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Abstract
Background Laparoscopic splenectomy (LS) is the stan-
dard procedure for normal size or moderately enlarged
spleens; open splenectomy (OS) is preferred in cases of
splenomegaly. In this study, indications for and compli-
cations of open and laparoscopic splenectomy were
analyzed, with the aim to identify patients who will benefit
from either technique.
Method A consecutive series of 52 patients undergoing
elective open or laparoscopic splenectomy between Janu-
ary 2001 and December 2006 was analyzed. Spleen volume
was calculated as length 9 width 9 depth from the
pathologist’s measurements.
Results LS was performed in 25 patients with a median age
of 41 years (range = 24–65). OS was performed in 27
patients with a median age of 60 years (range = 24–86)
(p \ 0.001). Conversion to OS was necessary in two patients
(8%). Operation time was significantly shorter in LS
(p \ 0.05). Spleen volume was significantly greater in
patients who underwent open (median = 2520 ml, range =
150–16,800 ml) versus laparoscopic (median = 648 ml,
range = 150–4860 ml) splenectomy (p = 0.001). In 36% of
all laparoscopic procedures, spleen volume exceeded
1000 ml. The underlying disease was mainly immuno-
thrombocytopenia in LS patients and lymphoma and
osteomyelofibrosis in OS patients. Five patients died after
OS. Significantly more patients were hospitalized longer
than 7 days following OS than following LS (p \ 0.05).
Overall complication rate was higher after OS (LS, 8; OS, 13
patients; p \ 0.05).
Conclusions LS was preferred in younger patients with
moderate splenomegaly, while massive splenomegaly
mostly led to OS. In view of the absence of technique-
related differences, LS can primarily be attempted in all
patients.
Introduction
Laparoscopic splenectomy (LS) rapidly gained widespread
acceptance for the treatment of nontraumatic diseases of the
spleen during the last 10 years. Increased technical skills
and technical developments have extended the indications
for the laparoscopic removal of the spleen [1]. General
indications for a total splenectomy are hemolytic anemias,
purpuras, secondary hypersplenism, and some other pri-
mary hematologic diseases [2]. Hematologic diseases such
as idiopathic thrombocytopenic purpura (ITP) and throm-
botic thrombocytopenic purpura (TTP) with normal or only
moderately enlarged spleens are still the most common
indications for a laparoscopic splenectomy [3]. Malignancy
is not a contraindication for a laparoscopic approach since it
has recently been demonstrated that morbidity and mortal-
ity of patients who underwent laparoscopic splenectomy for
benign or malignant diseases were not different and the
long-term survival was not impaired [4].
Massively enlarged spleens are often difficult to handle
intraoperatively, and there is concern about higher con-
version rates and higher morbidity [5]. Retrieving a large
specimen may require a long incision so that the benefits of
minimally invasive access of LS are wasted [5]. However,
the spleen can be morcellated and removed in a bag, with
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minimal risk of spleen cell spreading. Hence, patients with
a bulky spleen revealing a long axis of more than 20 cm are
commonly excluded from a laparoscopic approach [6].
Other authors advocate open splenectomy (OS) in patients
with a spleen larger than 1 kg or a splenic axis greater than
15 cm [7]. In contrast, it has been suggested that with
increasing experience, massively enlarged spleens can also
be safely removed by a laparoscopic approach [8].
Several studies from centers dedicated to laparoscopy
have shown the well-known advantages of minimally
invasive surgery, e.g., decreased postoperative pain, shorter
hospital stay, and reduced recovery time [9]. A recently
published meta-analysis revealed a significantly lower
complication rate after laparoscopic versus open splenec-
tomy; in particular, pulmonary complications, wound
infections, and systemic infectious complications were
decreased [10].
The aims of the current study were to assess the results
of open and laparoscopic splenectomy for nontraumatic
splenic diseases performed at a single center in the lapa-
roscopic era beyond the learning curve, and to identify
patients who will benefit from either technique.
Patients and methods
Patients
A consecutive series of 52 patients undergoing elective OS
or LS for various nontraumatic diseases at the Department
of Visceral and Transplantation Surgery, University Hos-
pital Zu¨rich, from January 2001 until December 2006 were
assessed retrospectively. Clinical data of all patients,
including age, gender, ASA classification, indication for
surgery, type of operation, intraoperative findings, operative
complications, conversion rate, blood loss, operating time,
postoperative morbidity, mortality, length of hospital stay,
and histologic and morphologic findings of the removed
specimen, were recorded in a database. The preoperative
spleen size was determined by varying techniques (ultra-
sound, CT scan, MRI). The spleen volume assessed in this
study was calculated as length 9 width 9 depth from the
pathologist’s measurements. In case of spleens that were
morcellated during LS, the pieces were reassembled by the
pathologist and then measured. The size was rather under-
estimated in those specimens.
Complications were classified and graded according to a
complication classification that was recently published by
our group [11]. Grade I and Grade II complications contain
minor deviations compared to a normal postoperative
course that can be treated with drugs, blood transfusion,
physiotherapy, and nutritional supply. Grade III compli-
cations are characterized by the need of interventional
treatment. Grade IV complications are life-threatening
complications with ICU management. Grade V means
death of the patient.
Operative techniques
Laparoscopic splenectomy was performed as previously
described [12, 13]. Briefly, patients were positioned in a
right lateral decubitus position. The stomach was decom-
pressed with a nasogastric tube, and an antibiotic single-
shot of 1 g cefazoline (Kefzol, Cerner Multum, Denver,
CO) was given intravenously. A 10-mm Hasson port was
inserted into the left medioclavicular line. Two 12-mm
ports were inserted under visual control along the costal
margin on the patient’s left side. A 10-mm 30 angled
telescope was used. Usually the dissection was performed
using a 5-mm ultrasonic dissector. The spleen was mobi-
lized starting at the lateroposterior side by dividing the
splenocolic and splenodiaphragmatic attachments. Then
the short gastric vessels were divided, and the splenic
hilum was completely freed. The pancreas was carefully
dissected from the splenic hilum. Splenic vessels were
divided using a 45-mm vascular stapler. Clips were used to
close additional segmental splenic vessels. Finally, the
spleen was put into an endoscopic bag, morcellated by
instrumental clamping or finger fraction, and retrieved
through an enlarged 15-mm trocar incision. The abdominal
cavity was carefully assessed for accessory spleens.
Open splenectomy was performed either through a
midline laparotomy or left subcostal incision, depending on
the individual surgeon’s preference. Then the lesser sac
was opened and the splenic artery was dissected at the
upper border of the pancreas, either using an endoscopic
vascular stapler or traditional ligatures. The spleen was
then completely freed.
All patients received pneumococcal and hemophilus B
vaccines either 2 weeks before or after surgery. Meningo-
coccal vaccines were not routinely given. All specimens
were assessed for histologic investigation.
Statistical analysis
Results were expressed as median and range values.
Groups were compared using Fisher’s exact test and the
Mann-Whitney test, where applicable. A p \ 0.05 was
considered statistically significant. All analyses were per-
formed using the SPSS v13.0 (SPSS, Inc., Chicago, IL).
Results
LS was performed in 25 patients, while 27 patients
underwent OS. Patients who had LS were significantly
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younger (LS, median age = 41 years, range = 24–
65 years; OS, median age = 60 years, range = 24–
86 years; p \ 0.001), and had a significantly lower ASA
score (ASA I: 1 patient, ASA II: 17 patients, ASA III: 6
patients, unknown: 1 patient) compared to OS patients
(ASA II: 11 patients, ASA III: 13 patients, ASA IV: 1
patient, undetermined: 2 patients) (p = 0.013). Preexisting
cardiovascular disease was similar (LS, 5 patients; OS, 8
patients, p = 0.37). The main underlying disease in the LS
group was autoimmune thrombocytopenia in 18 patients,
whereas OS was performed mostly for lymphoma (10
patients) or osteomyelofibrosis (7 patients). Three patients
underwent LS and four patients underwent OS for hair cell
leukemia. One patient underwent LS and three patients
underwent OS for infectious reasons (Table 1). Two
patients in the LS group and four patients in the OS group
had had previous abdominal surgery.
The operation time was significantly longer for OS
(median = 150 min, range = 70–260 min) than for LS
(median = 107.5 min, range = 50–390 min, p = 0.028).
Conversion from LS to OS was necessary in two
patients (8%). One patient had a massively enlarged spleen
that could not be handled laparoscopically, and the other
patient required conversion because of intraoperative
bleeding.
Intraoperative blood loss was significantly higher in OS
patients (OS, median blood loss = 400 ml, range = 50–
1500 ml; LS, median blood loss = 100 ml, range = 10–
1000 ml; p = 0.001). Intraoperative red blood cell substi-
tution was given in seven OS patients and in one LS patient
(p = 0.014). Platelet substitution was needed in three OS
patients. Preoperative thrombocytopenia less than 80,000/ll
was present in significantly more LS patients (LS, 13
patients, range = 13,000-67,000/ll; OS, 9 patients, range =
11,000-71,000/ll; p \ 0.05).
Additional surgical procedures were performed in both
groups. In the LS group, two patients underwent unplanned
left pancreas resection because the pancreas tail was
attached to the splenic hilum. In one patient, an accessory
spleen was detected intraoperatively and removed. In the
OS group, two left pancreas resections, one nephrectomy
because of a papillary renal cell carcinoma, one chole-
cystectomy, one staging laparotomy because of Hodgkin’s
disease, and one abdominal wall reconstruction were per-
formed. The operating time was longer in both groups
compared to that of splenectomy alone (LS ? additional
procedure, median time = 125 min, range = 105–140 min;
OS ? additional procedure, median time = 150 min,
range = 120–180 min).
Spleen volume was significantly greater in OS patients
(median volume = 2520 ml, range = 150–16,800 ml) than
in LS patients (median volume = 684 ml, range = 150–
4860 ml) (p = 0.001).
Length of hospital stay was not different for OS (med-
ian = 8.5 days, range = 3–26 days) and LS (median =
5 days, range = 2–146 days). The patient who stayed in
hospital for 146 days following LS received continued
treatment at a medical unit for his underlying disease; the
duration of his hospital stay was not related to the surgical
procedure. Therefore, hospital stay of longer than 7 days
was analyzed separately. Significantly more patients were
hospitalized more than 7 days after OS (14 patients) than
after LS (6 patients) (p \ 0.05).
There was no 30-day mortality following LS; one
patient died of multiorgan failure 26 days after OS. During
follow-up, four more patients following OS died of sepsis.
Overall complication rate (Table 2) was lower in patients
who underwent LS (LS, 8 patients, 23%; OS, 13 patients,
48%; p = 0.027). Preoperative steroid treatment was sig-
nificantly more frequent in patients who had LS (LS, 17
patients; OS, 9 patients; p \ 0.05), but no difference was
observed in postoperative infectious complications. Post-
operative pneumonia occurred in four patients following OS
and was not observed after LS. Postoperative fever of
unknown origin requiring antibiotic treatment developed in
five patients in each group. One patient developed aortic
valve endocarditis after OS and underwent successful
emergency aortic valve replacement. Deep vein thrombosis
(1 patient) and pulmonary embolism (1 patient) were
observed only after LS. Pancreatic fistula developed in three
Table 1 Patient charactistics
LS OS p value
Median age (years) 41 (24–65) 60 (24–86) \0.001
Male/female 13/12 18/9 ns
ASA II/III 17/6 11/13 0.013
Splenic disease
ITP 11 0
TTP 3 0
Hair cell leukemia 3 4
Myeloproliferative syndrome 0 8
Non-Hodgkin’s lymphoma 0 5
Chronic lymphatic leukemia 0 2
Other lymphoma 2 2
Splenic abscesses 0 3
Unclear splenomegaly 0 2
Hodgkin’s lymphoma 0 2
Spherocytosis 1 0
Autoimmune hemolytic anemia 3 0
Necrobiotic xantogranuloma 1 0
Unclear infection 1 0
Cystic spleenic lymphangioma 0 1
Splenomegaly and HIV 0 1
OS = open splenectomy; LS = laparoscopic splenectomy
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patients following LS; two patients underwent percutaneous
drainage and one patient was treated conservatively. None
of these three patients had undergone additional left lateral
pancreatic resection intraoperatively. No pancreatic fistula
was observed following OS. Reintervention because of
bleeding was not necessary following LS, but it occurred in
four patients following OS. In one of these patients,
superficial wound revision revealed the source of bleeding;
the other three patients required relaparotomy. Postopera-
tive portal vein thrombosis was not observed.
None of the patients who underwent LS experienced
higher-graded complications (Table 3) which required
intervention under anesthesia (Grade IIIb and above). All
complications following LS were graded I (3), II (3), and
IIIa (2). Following OS, no grade I complications occurred,
but higher-graded complications were more frequent (II: 4,
IIIa: 0, IIIb: 3, IVa: 0, IVb: 1, V: 5).
No late complications were observed in either group,
and no intervention for incisional hernia was necessary.
Discussion
In the present study, the results of a consecutive series of
52 patients who underwent elective total splenectomy for
various diseases of the spleen were assessed. The indica-
tion for elective splenectomy is given by the underlying
disease, whereas the technical approach is mainly deter-
mined by the size and weight of the spleen. The technical
approach (open or laparoscopic) was chosen by the indi-
vidual surgeon. Therefore, this study reflects the day-by-
day reality of the technical choice.
In general, severe splenomegaly is thought to interfere
with the laparoscopic approach [6, 14]. It has been sug-
gested that laparoscopic splenectomy be used only in
patients with a spleen weight lower than 1 kg, since
increased morbidity and a higher conversion rate were
previously reported for patients with larger spleens [5, 14].
However, it was demonstrated recently that massively
enlarged spleens of a craniocaudal length greater than
22 cm could be safely removed laparoscopically [9]. Dif-
ferent pathologies determine the size of the spleen, and a
direct outcome comparison of the morbidity of patients
who underwent OS or LS for the same underlying disease
is missing in the literature. Therefore, the increased mor-
bidity may not be related to the technique chosen but to the
underlying disease. In this study, 9 of the 25 spleens (36%)
removed laparoscopically reached a volume of larger than
1000 ml. This points out that the previously suggested limit
of 1 kg for laparoscopic surgery can be ignored and should
not be an absolute reason to abstain from a laparoscopic
procedure. Three of our patients had a spleen larger than
3000 ml. In one of these cases, a spleen of 4200 ml was the
reason for conversion; the other two were safely removed
laparoscopically.
There is no prospective randomized trial comparing OS
with LS, but several studies have shown the benefits of
minimally invasive surgery. Less pain, decreased surgical
morbidity, better cosmetic results, and a shortened hos-
pital stay have been attributed to LS [15]. Other reports
demonstrated only little [9, 16] or no shortening of the
hospital stay following laparoscopic intra-abdominal sur-
gery [17, 18]. In this series, the median hospital stay was
similar in both groups, but following LS, significantly
more patients left the hospital after less than 7 days. The
analysis of hospitalization time was complicated by the
fact that some patients were referred to a medical unit
following surgery to receive continued treatment for the
underlying disease. Therefore, the time of hospitalization
was overestimated in patients suffering from hematologic
disorders since postoperative hospital stay was not
determined only by the surgical procedure. This could
also apply to previously published studies although it was
not mentioned before.
Table 3 Severity of surgical complications following OS and LS
LS OS p value
Grade I 3 0 0.026
Grade II 3 4
Grade IIIa 2 0
Grade IIIb 0 3
Grade Iva 0 0
Grade Ivb 0 1
Grade V 0 5
Grade I: any deviation from the normal postoperative course without
the need for pharmacologic or surgical intervention. Grade II:
requiring pharmacologic treatment or blood transfusions. Grade III:
requiring surgical endoscopic or radiologic intervention (IIIa) under
local anesthesia or (IIIb) under general anesthesia. Grade IV: life-
threatening complication including, (IVa) single organ failure and
(IVb) multiorgan failure. Grade V: death. OS = open splenectomy;
LS = laparoscopic splenectomy
Table 2 Mortality and complications following OS and LS
LS OS p value
Overall mortality 0 5 0.052
within 30 days 0 1
Overall complications 8 13 0.027
Infection 5 5
Pneumonia 0 4
Rebleeding 0 4
Pancreatic fistula 3 0
Thromboembolic events 2 0
OS = open splenectomy; LS = laparoscopic splenectomy
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Patients who underwent LS in this study were about
20 years younger than those who had OS. It was previously
demonstrated that patients older than 65 years had a higher
overall complication rate after LS, but when stratified for
ASA scores, the complication rates of OS and LS were
similar [19]. This indicates that the patient’s biological age
alone should not guide the decision for laparoscopic or
open splenectomy. In this study, OS was clearly preferred
in patients with an ASA III score. However, OS was done
mainly for malignant diseases in elderly patients with a
higher ASA scores.
In contrast to previous reports [8, 10, 20], the median
operation time in this series was significantly shorter for LS
than for OS. This can be explained by several facts: LS was
performed only by experienced surgeons, whereas OS was
occasionally performed by younger surgeons as a teaching
operation. Alternatively, this may reflect a conservative
tendency of the surgeon: the open procedure was chosen
a priori in cases that were judged as difficult preoperatively
and in older patients with higher ASA scores. When there
were additional procedures, either independent of the
splenectomy or to treat complications, the median opera-
tion time was longer for both techniques, but again shorter
in the laparoscopic group. Therefore, OS did not show an
advantage with respect to complications.
Intraoperative bleeding during LS was a rare event and
led to conversion to OS in only one case. Estimated blood
loss was significantly lower in LS compared to OS. Portal
hypertension and the degree of liver cirrhosis, which were
previously identified as risk factors for high intraoperative
blood loss during LS [21], were not present in any of the
patients who had LS. In comparison, one patient in the OS
group had portal vein thrombosis, but blood loss was
moderate (400 ml) and transfusion was not necessary.
The conversion rate of 8% observed in this study was
lower than reported in similar studies [5, 8]. Conversion
was not related to the learning curve of the laparoscopic
procedure since the two conversion cases occurred in the
middle (year 2002) and the end (year 2006) of the obser-
vation period. It had been demonstrated before that the
conversion rate in LS was related to the institution’s
experience with this procedure [9]. Again, our low con-
version rate reflects a conservative attitude of the surgeon,
and open procedures were more likely to be chosen at the
outset. The data of this study indicate that at the beginning
of the observation period (years 2001 and 2002), OS was
chosen for ten patients, and only four patients had LS. At
the end of the observation period (years 2005 and 2006),
LS was performed in 11 patients, and OS was done in only
6 patients. This demonstrates a trend to more confidence in
the laparoscopic approach.
The overall complication rate of 33% was similar in
both groups [10]. Winslow and Brunt [10] found in their
meta-analysis an overall complication rate of 15% fol-
lowing LS. Complications in this study were mostly due to
pancreatic fistula (3 patients) and thromboembolic events
(2 patients), which did not occur after OS. Patients after OS
experienced pneumonia (4 patients) and bleeding (3
patients).
Low platelet count was reported to be associated with
higher morbidity [22]. Although in this study more patients
who underwent LS presented with thrombocytopenia, the
complication rate, including bleeding, was lower than in
patients who had OS. This demonstrates that LS is also safe
in the presence of a low platelet count. In line with other
studies [23], the need for erythrocyte and platelet substi-
tution was significantly lower in LS in this study, even
though significantly more patients who had LS had severe
thrombocytopenia before surgery. Because of the different
origins of thrombocytopenia in LS patients (mainly im-
munothrombopenia) and in OS patients (mainly
osteomyelofibrosis), this subgroup was not separately
compared.
Portal vein thrombosis, reported in up to 14% of patients
following LS [24], was not observed in this series, but was
assessed only if clinically suspected. It was reported pre-
viously that by routine postoperative helical CT scan,
portal vein thrombosis was detected in 55% of patients
after LS, but in only 19% of patients after OS [25]. The
subclinical incidence of portal vein thrombosis in this study
was possibly underdiagnosed.
In conclusion, LS was performed in younger patients
with moderate splenomegaly. Perioperative steroid treat-
ment did not increase the rate of infectious or wound
complications. Preoperative thrombocytopenia did not
complicate LS. The conversion rate to OS was low. There
were no technique-related differences between the two
procedures with respect to morbidity. LS should primarily
be attempted in all patients, if judged technically feasible
and if the general condition of the patient allows laparos-
copy. The size of the spleen alone should not drive the
decision to an open approach.
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